切换导航
关闭
  • 菜单
  • Setting

Signaling Pathways - Prostaglandin EP receptors - Calpains - Topoisomerases - Gap Junctions

26件产品中的 1-10

页面
每页
清除全部
  1. Gap 27
    A1045 Gap 27
     4 Citation
    Target: Gap Junctions
    Summary: 缝隙连接阻断剂
      ≥65.25 mg/mL
      ≥5 mg/mL
  2. Gap 26
    A1044 Gap 26
     8 Citation
    Target: Gap Junctions
    Summary: 间隙连接阻断肽,对应于connexin 43的63-75 aa。
      ≥77.55 mg/mL
      ≥155.1 mg/mL
  3. (S)-10-Hydroxycamptothecin
    B4745 (S)-10-Hydroxycamptothecin
    中文名: 羟喜树碱
    Target: Topoisomerases
    Summary: 拓扑异构酶I抑制剂
      ≥23.8 mg/mL
      insoluble in H2O
  4. Ellipticine
    B7382 Ellipticine
    中文名: 玫瑰树碱,椭圆玫瑰树碱
    Target: Topoisomerases
    Summary: DNA拓扑异构酶II抑制剂
      ≥24.6 mg/mL
      insoluble in H2O
  5. Prostaglandin E2
    B7005 Prostaglandin E2
    中文名: 前列腺素E2
    Target: Prostaglandin EP receptors
    Summary: 内源性前列腺素
      ≥42.8 mg/mL
      insoluble in H2O
  6. Pirarubicin
    B2295 Pirarubicin
     1 Citation
    中文名: 吡柔比星
    Target: Topoisomerases
    Summary: 拓扑异构酶II抑制剂,蒽环类抗生素
      ≥7.65 mg/mL
      insoluble in H2O
  7. Norfloxacin
    B1801 Norfloxacin
    中文名: 诺氟沙星
    Target: Topoisomerases
    Summary: 拓扑异构酶抑制剂
      insoluble in DMSO
      insoluble in H2O
  8. Irinotecan HCl Trihydrate
    B2293 Irinotecan HCl Trihydrate
    中文名: 盐酸依立替康三水合物
    Target: Topoisomerases
    Summary: 拓扑异构酶I抑制剂
      ≥23.1 mg/mL
      ≥2.5 mg/mL
  9. Beta-Lapachone
    B2290 Beta-Lapachone
    中文名: β-拉帕醌
    Target: Topoisomerases
    Summary: 选择性DNA拓扑异构酶I抑制剂
      ≥10.85 mg/mL
      insoluble in H2O
  10. Clinafloxacin CI96 AM1091
    A8400 Clinafloxacin CI96 AM1091
    中文名: 克林沙星
    Target: Topoisomerases
    Summary: 拓扑异构酶抑制剂
      ≥3.66 mg/mL
      insoluble in H2O

26件产品中的 1-10

页面
每页